CNClinicalTrials.govClinical trial
18F-grazy-02 PET/CT of Granzyme B Expression for Monitoring Immunotherapy
Phase 1/2RecruitingJul 31, 2026
Cancer types
Lymphoma
Hodgkin and non-Hodgkin lymphoma. 62 official records currently indexed across three regions.
Trial records retrieved live from the ClinicalTrials.gov public API.
Showing 62 of 62
Highlight terms:
USClinicalTrials.govClinical trial
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
Phase 1RecruitingJul 31, 2026
USEUCNOTHERClinicalTrials.govClinical trial
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Phase 3RecruitingJul 31, 2026
USClinicalTrials.govClinical trial
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
Not applicableRecruitingJul 31, 2026
USEUOTHERClinicalTrials.govClinical trial
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Phase 3RecruitingJul 31, 2026
EUCNOTHERClinicalTrials.govClinical trial
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Phase 1Enrolling by invitationJul 31, 2026
EUOTHERClinicalTrials.govClinical trial
A Study of JNJ-87801493 in Combination With T-Cell Engagers in Participants With B-cell Non-Hodgkin Lymphoid (NHLs) Cancer
Phase 1Active, not recruitingJul 31, 2026
EUCNOTHERClinicalTrials.govClinical trial
A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Phase 1Active, not recruitingJul 31, 2026
USEUOTHERClinicalTrials.govClinical trial
A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)
Phase 1Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trial
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
Phase 1RecruitingJul 31, 2026
USEUCNOTHERClinicalTrials.govClinical trial
A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies
Phase 2Active, not recruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trial
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Phase 3RecruitingJul 31, 2026
USEUOTHERClinicalTrials.govClinical trial
A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia
Phase 2Active, not recruitingJul 31, 2026
USEUCNOTHERClinicalTrials.govClinical trial
A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma
Phase 2Active, not recruitingJul 31, 2026
USEUOTHERClinicalTrials.govClinical trial
An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis
Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trial
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Phase 1RecruitingJul 31, 2026
USClinicalTrials.govClinical trial
Blinatumomab Consolidation in Real World
RecruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Phase 3Active, not recruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trial
Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial
Phase 2RecruitingJul 31, 2026
USClinicalTrials.govClinical trial
Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome
Phase 1Active, not recruitingJul 31, 2026
USEUCNOTHERClinicalTrials.govClinical trial
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Phase 2RecruitingJul 31, 2026
EUClinicalTrials.govClinical trial
Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia With TP53 Alterations
Phase 2Not yet recruitingJul 31, 2026
USClinicalTrials.govClinical trial
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase 3Active, not recruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trial
Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Phase 3Active, not recruitingJul 31, 2026
OTHERClinicalTrials.govClinical trial
Modified DHAP Versus Standard DHAP in Relapsed/Refractory Diffused Large B-cell Lymphoma.
Phase 3RecruitingJul 31, 2026
USClinicalTrials.govClinical trial
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
RecruitingJul 31, 2026
USClinicalTrials.govClinical trial
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
Phase 3RecruitingJul 31, 2026
USClinicalTrials.govClinical trial
Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trial
Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers
Phase 2Not yet recruitingJul 31, 2026
EUClinicalTrials.govClinical trial
Study of Zanubrutinib in Older Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Phase 2Not yet recruitingJul 31, 2026
OTHERClinicalTrials.govClinical trial
Study to Assess Change in Disease Activity of Oral Venetoclax in Adult Participants With Recurring Relapsed or Refractory (R/R) Waldenström Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
Phase 2Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trial
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
Phase 2Active, not recruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Phase 2Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trial
Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma
Phase 1Active, not recruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trial
Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma
Phase 2Active, not recruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trial
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Phase 3RecruitingJul 31, 2026
USClinicalTrials.govClinical trial
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
Phase 1RecruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trial
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Phase 2RecruitingJul 31, 2026
USClinicalTrials.govClinical trial
Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy
Phase 2RecruitingJul 31, 2026
USClinicalTrials.govClinical trial
Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene
Phase 1/2RecruitingJul 31, 2026
CNCDERegulatory
CDE 临床试验默示许可 — clinical trial implied licence notices
Continuously updated
CNCDERegulatory
CDE 优先审评公示 — priority review listings
Continuously updated
CNCDERegulatory
CDE 受理品种信息 — applications accepted for review
Continuously updated
CNCDEGuideline
CDE 指导原则 — published technical guidance documents
Continuously updated
CNCDERegulatory
CDE 突破性治疗公示 — breakthrough therapy designation notices
Continuously updated
CNCDERegulatory
CDE 附条件批准品种 — conditionally approved products list
Continuously updated
CNChiCTRRegistry
ChiCTR — Chinese Clinical Trial Registry, public search
Continuously updated
EUCTISRegistry
CTIS public register — search clinical trials authorised in the EU/EEA
Continuously updated
EUEMARegulatory
EMA — CHMP meeting highlights and opinions on new medicines
Continuously updated
EUEMARegulatory
EMA — medicines for human use currently under evaluation (monthly CHMP list)
Continuously updated
EUEMARegulatory
EMA — searchable database of authorised medicines in the EU
Continuously updated
EUESMOGuideline
ESMO Clinical Practice Guidelines — haematological malignancies
Continuously updated
EUESMOGuideline
ESMO Clinical Practice Guidelines — public index by tumour type
Continuously updated
EUESMOGuideline
ESMO Clinical Practice Guidelines — supportive and palliative care section
Continuously updated
USFDARegulatory
FDA — expanded access (compassionate use) information for patients
Continuously updated
USFDARegulatory
FDA — oncology (cancer) / hematologic malignancies approval notifications
Continuously updated
USFDARegulatory
FDA — ongoing accelerated approvals for oncology indications
Continuously updated
USNCCNGuideline
NCCN Guidelines — palliative care category listing
Continuously updated
USNCCNGuideline
NCCN Guidelines — public index by cancer type (free registration)
Continuously updated
USNCCNGuideline
NCCN Guidelines for Patients — plain-language versions
Continuously updated
CNNMPARegulatory
NMPA 药品 — national drug approval announcements
Continuously updated
CNCDERegistry
药物临床试验登记与信息公示平台 — national registry of drug trials conducted in China
Continuously updated
This site does not provide medical advice
TrialBeacon only aggregates links to publicly available official information. It does not recommend, rank or evaluate any treatment, trial or medicine, and nothing here implies suitability for any individual. Please discuss anything you find with your treating doctor, and always rely on the original official page — records change over time. Full disclaimer.